Join
Live feed
·
INSIDERFilingvia Quantisnow
Entrada Therapeutics Inc. logo

CEO Doshi Dipal covered exercise/tax liability with 8,724 shares, decreasing direct ownership by 2% to 517,290 units (SEC Form 4) to satisfy withholding tax

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TRDA (Entrada Therapeutics Inc.) and more on Quantisnow.